NIDDM and its metabolic control predict coronary heart disease in elderly subjects - PubMed (original) (raw)
NIDDM and its metabolic control predict coronary heart disease in elderly subjects
J Kuusisto et al. Diabetes. 1994 Aug.
Abstract
The aim of this study was to evaluate whether noninsulin-dependent diabetes (NIDDM) and its metabolic control and duration predict coronary heart disease (CHD) events during a 3.5-year follow-up in a randomly selected Finnish population sample 65-74 years of age at baseline. Of 1,298 subjects participating in the baseline study, 1,069 were nondiabetic and 229 had NIDDM. During the follow-up, 3.4% of nondiabetic and 14.8% of NIDDM subjects died from CHD or had a nonfatal myocardial infarction (MI). The impact of NIDDM on CHD mortality and morbidity was more marked in women than in men. Odds ratios (ORs) and their 95% confidence intervals for CHD death and nonfatal MI in women with NIDDM compared with women with normal glucose tolerance were 11.7 (3.8-36.4) and 4.7 (3.6-6.1). In men, the corresponding ORs were 0.43 (0.1-1.9) and 1.4 (0.6-3.2). In multiple logistic regression analyses including all study subjects, NIDDM (P < 0.01), male sex (P < 0.05), and previous MI (P < 0.01) predicted CHD death (n = 45). NIDDM (P < 0.01), male sex (P < 0.05), previous MI (P < 0.05), current smoking (P < 0.001), systolic blood pressure (P < 0.001), and low high-density lipoprotein cholesterol (P < 0.01) predicted all CHD events (CHD death or nonfatal MI) (n = 107). In NIDDM subjects, only glycated hemoglobin A1c (GHbA1c) at baseline (P < 0.01) and duration of diabetes (P < 0.05) predicted CHD death (n = 15) and all CHD events (n = 33). There was a significant increase in the risk of CHD death and all CHD events in NIDDM subjects with GHbA1c levels higher than 7.0% compared with diabetic subjects with lower GHbA1c (ORs 4.3 [1.1-16.7] and 2.2 [1.0-5.1]). In conclusion, NIDDM and its metabolic control and the duration of diabetes are important predictors of CHD in elderly subjects, particularly in women.
Similar articles
- Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects.
Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Kuusisto J, et al. Stroke. 1994 Jun;25(6):1157-64. doi: 10.1161/01.str.25.6.1157. Stroke. 1994. PMID: 8202973 - Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations?
Laakso M, Rönnemaa T, Lehto S, Puukka P, Kallio V, Pyörälä K. Laakso M, et al. Diabetologia. 1995 Apr;38(4):487-93. doi: 10.1007/BF00410288. Diabetologia. 1995. PMID: 7796991 - Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
Laakso M, Lehto S, Penttilä I, Pyörälä K. Laakso M, et al. Circulation. 1993 Oct;88(4 Pt 1):1421-30. doi: 10.1161/01.cir.88.4.1421. Circulation. 1993. PMID: 8403288 - The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities.
Haffner SM. Haffner SM. J Diabetes Complications. 1997 Mar-Apr;11(2):69-76. doi: 10.1016/s1056-8727(96)00099-2. J Diabetes Complications. 1997. PMID: 9101390 Review. - Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis.
Kanaya AM, Grady D, Barrett-Connor E. Kanaya AM, et al. Arch Intern Med. 2002 Aug 12-26;162(15):1737-45. doi: 10.1001/archinte.162.15.1737. Arch Intern Med. 2002. PMID: 12153377 Review.
Cited by
- Association of prediabetes with clinical outcomes in patients with chronic coronary syndrome: a post hoc analysis of the ISCHEMIA and ISCHEMIA-CKD trials.
Jorda A, Hengstenberg C, Lang IM, Kautzky-Willer A, Harreiter J, Zeitlinger M, Jilma B, Gelbenegger G. Jorda A, et al. Cardiovasc Diabetol. 2024 May 20;23(1):176. doi: 10.1186/s12933-024-02232-z. Cardiovasc Diabetol. 2024. PMID: 38769562 Free PMC article. Clinical Trial. - Characteristics of Postoperative Patients with Breast Cancer Aged 65 Years and Older.
Akezaki Y, Nakata E, Kikuuchi M, Tominaga R, Kurokawa H, Okamoto M, Ozaki T, Aogi K, Ohsumi S, Sugihara S. Akezaki Y, et al. Curr Oncol. 2023 Jan 4;30(1):673-680. doi: 10.3390/curroncol30010052. Curr Oncol. 2023. PMID: 36661701 Free PMC article. - Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers.
Prandi FR, Lecis D, Illuminato F, Milite M, Celotto R, Lerakis S, Romeo F, Barillà F. Prandi FR, et al. Int J Mol Sci. 2022 Apr 21;23(9):4589. doi: 10.3390/ijms23094589. Int J Mol Sci. 2022. PMID: 35562979 Free PMC article. Review. - Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana.
Rwegerera GM, Shailemo DHP, Pina Rivera Y, Mokgosi KO, Bale P, Oyewo TA, Luis BD, Habte D, Godman B. Rwegerera GM, et al. Diabetes Metab Syndr Obes. 2021 Jan 11;14:85-97. doi: 10.2147/DMSO.S285720. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33469326 Free PMC article. - Influence of gender on the distribution of type 2 diabetic complications at the obafemi awolowo teaching hospital, Ile-Ife, Nigeria.
Enikuomehin A, Kolawole BA, Soyoye OD, Adebayo JO, Ikem RT. Enikuomehin A, et al. Afr Health Sci. 2020 Mar;20(1):294-307. doi: 10.4314/ahs.v20i1.35. Afr Health Sci. 2020. PMID: 33402918 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical